During the past decade, Korea university Guro hospital conducted 306 clinical trials. In the 10-year time frame, 306 clinical trials started and 72 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 135 clinical trials started and 52 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Korea university Guro hospital" #1 sponsor was "Korea University Guro Hospital" with 41 trials, followed by "Seung-Jung Park" with 26 trials sponsored, "Hoffmann-La Roche" with 25 trials sponsored, "Korea University" with 17 trials sponsored and "Chong Kun Dang Pharmaceutical" with 17 trials sponsored. Other sponsors include 294 different institutions and companies that sponsored additional 154 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Korea university Guro hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 31 trials as a collaborator, "Korea University Guro Hospital" with 17 trials as a collaborator, "Samsung Medical Center" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 7 trials as a collaborator and "Eli Lilly and Company" with 6 trials as a collaborator. Other collaborators include 250 different institutions and companies that were collaborators in the rest 155 trials.

According to Clinical.Site data, the most researched conditions in "Korea university Guro hospital" are "Coronary Artery Disease" (29 trials), "Hypertension" (13 trials), "Atherosclerosis" (12 trials), "Atrial Fibrillation" (11 trials) and "Breast Cancer" (10 trials). Many other conditions were trialed in "Korea university Guro hospital" in a lesser frequency.

Most popular intervention types in "Korea university Guro hospital" are "Drug" (270 trials), "Biological" (50 trials), "Device" (44 trials), "Other" (28 trials) and "Procedure" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (75 trials), "Atezolizumab" (12 trials), "Paclitaxel" (12 trials), "Gemcitabine" (11 trials) and "Cisplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Korea university Guro hospital" are 381 trials for "All" genders, 32 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Korea university Guro hospital". 3 are not yet recruiting, 77 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 198 completed trials in Korea university Guro hospital, undefined suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Korea university Guro hospital, 33 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 137 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 36 trials that are defined as “Not Applicable".